Search Results
Slidesets
Current Insights in Diagnosis and Viral Monitoring of SARS-Cov-2 Infections - Annemarie Wensing, MD, PhD
Presented at:
COVID-19 Clinical Forum 2021
Abstracts
Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates
C. Charpentier
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Slidesets
Virologic and Immunologic Responses to Raltegravir and Dolutegravir in GALT of HIV+ Men and Women - Michael Weber, PharmD
Presented at:
International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy 2016
Slidesets
Francis Ssali, MBChB - Rapid Start – In Practice: Clinical Case
Presented at:
African HIV Clinical Forum 2022
Slidesets
Whatever Happened with PEP - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipGUM, DFSRH
Presented at:
HIV Prevention Summit 2021
Slidesets
Starting PrEP During Acute HIV Infection: What is the Risk for Antiretroviral Drug Resistance? - Donn Colby
Presented at:
Asia-Pacific HIV Clinical Forum 2019
Slidesets
Challenges in Monitoring (POC) | Isabelle Andrieux-Meyer
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016